Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.655
-0.245-4.15%
Volume:4.10M
Turnover:22.95M
Market Cap:9.03B
PE:-17.97
High:5.895
Open:5.895
Low:5.420
Close:5.900
52wk High:10.410
52wk Low:4.010
Shares:1.60B
HK Float Shares:1.60B
Volume Ratio:0.59
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.315
ROE:-52.14%
ROA:-14.44%
PB:5.97
PE(LYR):-17.97
PS:18.14

Loading ...

CStone Pharmaceuticals plans market buyback of up to 136,450,133 shares

Reuters
·
May 13

CStone Pharmaceuticals Begins Commercial Distribution of Locally Manufactured Pralsetinib

MT Newswires Live
·
May 11

CSTONE PHARMA-B Initiates Nationwide Commercial Distribution of Locally Produced Pralsetinib Capsules

Stock News
·
May 11

CStone launches nationwide distribution of China-made pralsetinib; projects 2026 sales above RMB 0.30 billion

Bulletin Express
·
May 11

CStone expects 2026 pralesatinib capsule sales revenue to top CNY 300 million

Reuters
·
May 11

CStone Pharmaceuticals - Begins Nationwide Commercial Supply of Locally Manufactured Pralsetinib Capsules

THOMSON REUTERS
·
May 11

CStone Pharma Issues 124.23 Million New Shares in April, Expanding Share Base to 1.60 Billion

Bulletin Express
·
May 07

Stock Track | CStone Pharmaceuticals-B Plummets 5.17% Intraday on Share Placement Dilution and Widening Annual Losses

Stock Track
·
Apr 28

CSTONE PHARMA-B 2025年净亏损达4.37亿元,创新管线投入加速推进

Bulletin Express
·
Apr 27

CStone Pharmaceuticals publishes 2025 annual report

Reuters
·
Apr 27

Stock Track | CStone Pharma-B Plummets 5.90% Intraday on Share Placement Dilution Concerns

Stock Track
·
Apr 24

CStone Pharmaceuticals raises HK$1.05 billion through placing of 118 million new shares, expanding capital base by 7.40%

Bulletin Express
·
Apr 22

CSTONE PHARMA-B Allots 118 Million New Shares Under Placement Agreement

Stock News
·
Apr 22

CStone files HKEX next-day return for 118,000,000-share issue at HKD 8.97

Reuters
·
Apr 22

Stock Track | CSTONE PHARMA-B Soars 5.10% Intraday on Positive CS2009 Clinical Data for ASCO Presentation

Stock Track
·
Apr 22

CSTONE PHARMA-B Shares Surge Nearly 5% at Open, Set to Reveal Key CS2009 Clinical Milestones at 2026 ASCO Conference

Deep News
·
Apr 22

Key Clinical Milestones for CSTONE PHARMA-B's CS2009 to be Presented at ASCO Annual Meeting

Stock News
·
Apr 22

CStone to present updated CS2009 phase 1/2 NSCLC data at ASCO 2026

Reuters
·
Apr 22

HHLR Advisors Increases Stake in CStone Pharma by 26.2 Million Shares at HK$8.97 Each

Stock News
·
Apr 21

CStone Pharmaceuticals Showcases Preclinical Findings for Three Novel ADC Candidates at AACR Conference

Stock News
·
Apr 20